An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 104 of the 105 references it cites were found in a registry or an index.
Abstract
Oxidative stress has been linked with a variety of diseases, being involved in the debut and/or progress of several neurodegenerative disorders. This review intends to summarize some of the findings that correlate the overproduction of reactive oxygen species with the pathophysiology of Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. Oxidative stress was also noted to modify the inflammatory response. Even though oxidative stress and neuroinflammation are two totally different pathological events, they are linked and affect one another. Nonetheless, there are still several mechanisms that need to be understood regarding the onset and the progress of neurodegenerative diseases in order to develop efficient therapies. As antioxidants are a means to alter oxidative stress and slow down the symptoms of these neurodegenerative diseases, the most common antioxidants, enzymatic as well as non-enzymatic, have been mentioned in this paper as therapeutic options for the discussed disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Generally known reactive oxygen species (ROS). Adapted from [13].](https://figures.cochat.ai/paper-figures/9dc1d012e9e34e18822030ec89569bfb/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-1.jpg)
![Figure 2 Dopamine metabolism and ROS production. Reprinted from an open-access source [21].](https://figures.cochat.ai/paper-figures/3cc9438ebe354aeab026d8ea3f0ad7cc/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-2.jpg)
![Figure 3 Schematic representation of alterations in dopamine, iron, and alfa-synuclein promoting oxidative stress in the substantia nigra pars compacta. Reprinted from an open-access source [21].](https://figures.cochat.ai/paper-figures/79d7743213bd4acd8dc276da40dae43e/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-3.jpg)
![Figure 4 The model of motor nerve terminal dysregulation in ALS. (A) Healthy NMJ. (B) Pathological changes in NMJ during early stage of ALS. (C) Pathological changes in NMJ during late stage of ALS. Abbreviations: Ach—acetyl choline, MuSK—muscle-specific kinase, NMJ—neuromuscular junction, ROS—reactive oxygen species, TSC—terminal Schwann. Reprinted from an open-access source [34].](https://figures.cochat.ai/paper-figures/2e64b95026e34c5ab6b7ccd689373902/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-4.jpg)
![Figure 5 Representation of ROS-induced mitochondrial abnormalities in AD. Reprinted from an open-access source [9].](https://figures.cochat.ai/paper-figures/43a7b1a13867494ca7957071279194b2/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-5.jpg)
![Figure 6 Mutant HTT (mHTT)-induced mitochondria-mediated reactive oxygen species (ROS) accumulation. Adapted from [62].](https://figures.cochat.ai/paper-figures/b96903214a6042b4b49c7465333ed8f1/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-6.jpg)
![Figure 7 Overview of microglial functions in response to stress and AD pathology. Adapted from [71].](https://figures.cochat.ai/paper-figures/982c0e0a6c73429884ec1275432bb076/an-overview-of-oxidative-stress-neuroinflammation-and-neurodegenerative-diseases-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within this context, ω3 are able to ameliorate oxidative stress and neuroinflammation, which may explain part of their beneficial effects on PD [457].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [457]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
Ighodaro, O. M., & Akinloye, O. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.09.001 · Cited by 3,939
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · cited 4×
“In more detail, high oxygen consumption, low antioxidant levels, and low regenerative capacity were observed to induce oxidative damage susceptibility in brain tissues [7].”
BackgroundInfluentialOxidative Stress: A Key Modulator in Neurodegenerative Diseases
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,254
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · cited 1×
“Moreover, due to the lowering of estrogen levels during menopause and longer life expectancy, women are more likely to develop AD than men [42,43].”
BackgroundOxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · cited 2×
“sible for learning and memory, which are affected in AD brains [48].”
BackgroundA blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853 · cited 1×
“Because the therapeutic agents need to reach the central nervous system (CNS), it is necessary to tailor appropriate vectors that can surpass the brain–blood barrier (BBB) [3,6].”
BackgroundHardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.71 · Cited by 1,414
The role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355 · cited 9×
“dehydrogenase, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) [13,15].”
BackgroundInfluential13 reasons why the brain is susceptible to oxidative stress
Cobley, J. N., Fiorello, M. L., & Bailey, D. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.008 · Cited by 1,215
Role of oxidative stress in Alzheimer’s disease
HUANG, W.-J., ZHANG, X., & CHEN, W.-W. (2016) · Biomedical Reports · doi:10.3892/br.2016.630 · Cited by 1,023
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders
Islam, M. T. (2017) · Neurological Research · doi:10.1080/01616412.2016.1251711 · Cited by 983 · cited 6×
“The initiation of the disease can occur in individuals as young as 35 years old [59,60].”
BackgroundInfluentialInflammation in CNS neurodegenerative diseases
Stephenson, J., Nutma, E., van der Valk, P., & Amor, S. (2018) · Immunology · doi:10.1111/imm.12922 · Cited by 966
Role of ROS and Nutritional Antioxidants in Human Diseases
Liu, Z., Ren, Z., Zhang, J., Chuang, C.-C., Kandaswamy, E., Zhou, T., & Zuo, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00477 · Cited by 860
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., & Zuo, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2525967 · Cited by 810 · cited 10×
“the adverse effects of free radicals can be diminished by antioxidants and fruits, such as vitamin C and E [1].”
BackgroundInfluentialRole of mitochondrial ROS in the brain: from physiology to neurodegeneration
Angelova, P. R., & Abramov, A. Y. (2018) · FEBS Letters · doi:10.1002/1873-3468.12964 · Cited by 789 · cited 2×
“The reason for this can either be a free radical enhancement or a reduction in the defense of antioxidants [1,44,45].”
BackgroundTherapeutic potentials of superoxide dismutase.
Younus, H. (2018) · PubMed Central · Cited by 787
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778 · cited 4×
“α-synucleinVMAT2 interaction also regulates the fusion and clustering of tSNARE-associated vesicles to the presynaptic membrane [21].”
BackgroundInfluentialKojima, R., Bojar, D., Rizzi, G., Hamri, G. C.-E., El-Baba, M. D., Saxena, P., Ausländer, S., Tan, K. R., & Fussenegger, M. (2018) · Nature Communications · doi:10.1038/s41467-018-03733-8 · Cited by 748 · cited 1×
“Catalase treatment was reported to ameliorate memory deficit in AD [84], attenuate neurotoxicity and neuroinflammation [85], and provide significant neuroprotective effects in PD [86].”
BackgroundMitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
Misrani, A., Tabassum, S., & Yang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.617588 · Cited by 654
Neuroprotective Effects of Quercetin in Alzheimer’s Disease
Khan, H., Ullah, H., Aschner, M., Cheang, W. S., & Akkol, E. K. (2019) · Biomolecules · doi:10.3390/biom10010059 · Cited by 537 · cited 1×
“This flavonoid was noticed to protect neurons from oxidative damage, reduce lipid peroxidation, inhibit the fibril formation of amyloid-β protein, and counteract cell lyses and inflammatory cascade pathways, thus being a promising alternative for treating AD [97,98].”
BackgroundHartl, F. U. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044518 · Cited by 520
Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View
Cenini, G., Lloret, A., & Cascella, R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2105607 · Cited by 499
Molecular targets of oxidative stress
Avery, S. V. (2011) · Biochemical Journal · doi:10.1042/bj20101695 · Cited by 474 · cited 2×
“Protein oxidation is also increasingly recognized as relevant, especially because oxidized proteins may gain a toxic function by forming cytotoxic aggregates [16,17].”
BackgroundSolleiro-Villavicencio, H., & Rivas-Arancibia, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00114 · Cited by 463
Martin-Bastida, A., Ward, R. J., Newbould, R., Piccini, P., Sharp, D., Kabba, C., Patel, M. C., Spino, M., Connelly, J., Tricta, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01402-2 · Cited by 379 · cited 2×
“these studies to fully assess the neuroprotective effects of deferiprone [24].”
BackgroundCoenzyme Q10 Supplementation in Aging and Disease
Hernández-Camacho, J. D., Bernier, M., López-Lluch, G., & Navas, P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00044 · Cited by 366
Bisht, K., Sharma, K., & Tremblay, M.-È. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.05.003 · Cited by 360 · cited 2×
“the clearance of aggregated Aβ, it is noted that the activation of pro-inflammatory signaling pathways promotes inflammation, oxidative stress, and neurodegeneration in AD [70,71].”
BackgroundManagement of oxidative stress and other pathologies in Alzheimer’s disease
Simunkova, M., Alwasel, S. H., Alhazza, I. M., Jomova, K., Kollar, V., Rusko, M., & Valko, M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02538-y · Cited by 303 · cited 2×
“physiological processes governed by metalloenzymes [49].”
BackgroundMolecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease
Zaplatic, E., Bule, M., Shah, S. Z. A., Uddin, M. S., & Niaz, K. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.055 · Cited by 293 · cited 1×
“This flavonoid was noticed to protect neurons from oxidative damage, reduce lipid peroxidation, inhibit the fibril formation of amyloid-β protein, and counteract cell lyses and inflammatory cascade pathways, thus being a promising alternative for treating AD [97,98].”
BackgroundShinto, L., Quinn, J., Montine, T., Dodge, H. H., Woodward, W., Baldauf-Wagner, S., Waichunas, D., Bumgarner, L., Bourdette, D., Silbert, L., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130722 · Cited by 288 · cited 1×
“However, given that the results were generated from a small sample size (39 participants, out of which 34 completed the 12-month intervention), further evaluation of the combined treatment is needed [50].”
BackgroundOverview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
Tardiolo, G., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23123305 · Cited by 285 · cited 2×
“Moreover, NAC holds promising potential in association with other drugs to create efficient combined therapies for neurodegenerative disorders [101].”
BackgroundNeuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants
Ayaz, M., Sadiq, A., Junaid, M., Ullah, F., Subhan, F., & Ahmed, J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00168 · Cited by 281
Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics
Cassidy, L., Fernandez, F., Johnson, J. B., Naiker, M., Owoola, A. G., & Broszczak, D. A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102294 · Cited by 275 · cited 3×
“Thus, there appears to be a positive feedback loop of enhanced oxidation and enhanced ROS production [46].”
BackgroundInfluentialChen, R., Lai, U. H., Zhu, L., Singh, A., Ahmed, M., & Forsyth, N. R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00132 · Cited by 269 · cited 1×
“dehydrogenase, and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) [13,15].”
BackgroundDoes Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?
Kocot, J., Luchowska-Kocot, D., Kiełczykowska, M., Musik, I., & Kurzepa, J. (2017) · Nutrients · doi:10.3390/nu9070659 · Cited by 242
Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly
Kumar, A., & Ratan, R. R. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160205 · Cited by 236 · cited 2×
“Despite strong evidence linking OS and HD, attempts to cure the disease with classic antioxidants have mostly been inefficient [1,67].”
BackgroundConcise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases
Volkman, R., & Offen, D. (2017) · Stem Cells · doi:10.1002/stem.2651 · Cited by 222 · cited 1×
“Because the therapeutic agents need to reach the central nervous system (CNS), it is necessary to tailor appropriate vectors that can surpass the brain–blood barrier (BBB) [3,6].”
BackgroundMolecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204 · cited 2×
“HNE can be detected at the early stages of AD progress, while its levels have been reported to be proportional to the extent of neuronal lesions [47].”
BackgroundVenkateshappa, C., Harish, G., Mythri, R. B., Mahadevan, A., Srinivas Bharath, M. M., & Shankar, S. K. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0619-7 · Cited by 177 · cited 2×
“Although the exact process that determines dopaminergic neuronal loss is not clear, it has been suggested that ROS is one of the key factors [1,13,23] (Figure 2).”
BackgroundClinical Applications of Artificial Intelligence—An Updated Overview
Busnatu, Ș., Niculescu, A.-G., Bolocan, A., Petrescu, G. E. D., Păduraru, D. N., Năstasă, I., Lupușoru, M., Geantă, M., Andronic, O., Grumezescu, A. M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082265 · Cited by 172
Self-citationSriraksa, N., Wattanathorn, J., Muchimapura, S., Tiamkao, S., Brown, K., & Chaisiwamongkol, K. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/823206 · Cited by 164 · cited 1×
“Quercetin was also reported to have a cognition-enhancing effect in rat models of PD attributed to its role in decreasing oxidative damage [99].”
BackgroundSelenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington’s Disease
Cong, W., Bai, R., Li, Y.-F., Wang, L., & Chen, C. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12319 · Cited by 162
Superoxide dismutase as multipotent therapeutic antioxidant enzyme: Role in human diseases
Saxena, P., Selvaraj, K., Khare, S. K., & Chaudhary, N. (2022) · Biotechnology Letters · doi:10.1007/s10529-021-03200-3 · Cited by 160 · cited 1×
“Thus, tackling SOD has been proven a useful tool against various diseases [78,79], including AD [80], PD [81], and ALS [82,83].”
The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease
Lloret, A., Esteve, D., Monllor, P., Cervera-Ferri, A., & Lloret, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040879 · Cited by 159 · cited 1×
“In addition to its antioxidant and neuroprotector roles, vitamin E is also involved in anti-inflammatory processes and cell signaling [89].”
BackgroundPollari, E., Goldsteins, G., Bart, G., Koistinaho, J., & Giniatullin, R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00131 · Cited by 150 · cited 6×
“progression of the disorder, OS being a priority [34] (Table 2).”
BackgroundInfluentialObrador, E., Palmer, R. S., López‐Blanch, R., Jihad-Jebbar, A., Vallés, S. L., & Estrela, J. M. (2020) · Antioxidants · doi:10.3390/antiox9090901 · Cited by 147 · cited 3×
“Therefore, the inflammatory response does not perform accordingly, generating neuroinflammation in CNS [31,60,69].”
BackgroundEuch, S. K. E., Hassine, D. B., Cazaux, S., Bouzouita, N., & Bouajila, J. (2018) · South African Journal of Botany · doi:10.1016/j.sajb.2018.07.010 · Cited by 140
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
Schirinzi, T., Martella, G., Imbriani, P., Di Lazzaro, G., Franco, D., Colona, V. L., Alwardat, M., Sinibaldi Salimei, P., Mercuri, N. B., Pierantozzi, M., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00148 · Cited by 138 · cited 1×
“Moreover, the lack of vitamin E in the human body has been linked with the incidence of neurodegenerative disorders [72,87].”
BackgroundWang, W.-W., Han, R., He, H.-J., Li, J., Chen, S.-Y., Gu, Y., & Xie, C. (2021) · Aging · doi:10.18632/aging.202868 · Cited by 128
Ayaz, M., Junaid, M., Ullah, F., Sadiq, A., Khan, M. A., Ahmad, W., Shah, M. R., Imran, M., & Ahmad, S. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0145-8 · Cited by 127
He, X.-B., Kim, M., Kim, S.-Y., Yi, S.-H., Rhee, Y.-H., Kim, T., Lee, E.-H., Park, C.-H., Dixit, S., Harrison, F. E., et al. (2015) · Stem Cells · doi:10.1002/stem.1932 · Cited by 119 · cited 1×
“it can enhance the embryonic midbrain neural stem cells’ differentiation into dopaminergic neurons [88,91].”
BackgroundA Mitochondria-Associated Oxidative Stress Perspective on Huntington’s Disease
Zheng, J., Winderickx, J., Franssens, V., & Liu, B. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00329 · Cited by 119 · cited 1×
“In healthy individuals, the CAG segment is repeated approximately 25 times in the HTT gene, whereas individuals with 40–50 repeats develop adult-onset HD, and those with more than 60 CAG repeats tend to manifest HD at a young age [62].”
BackgroundAnti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View
Filograna, R., Beltramini, M., Bubacco, L., & Bisaglia, M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666151030102718 · Cited by 110 · cited 1×
“Moreover, their utilization must be closely monitored, because although they can be beneficial, excessive use can trigger the disease instead of preventing it [72,75,76].”
BackgroundProtein oxidation in Huntington disease affects energy production and vitamin B6 metabolism
Sorolla, M. A., Colman, M. J. R., Tamarit, J., Ortega, Z., Lucas, J. J., Ferrer, I., Ros, J., & Cabiscol, E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.016 · Cited by 108
Benefits of Vitamins in the Treatment of Parkinson’s Disease
Zhao, X., Zhang, M., Li, C., Jiang, X., Su, Y., & Zhang, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9426867 · Cited by 105
Oxidative Stress and Free Radical Damage in Neurology
(2011) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9 · Cited by 101
Ahmad, S., Ullah, F., Sadiq, A., Ayaz, M., Imran, M., Ali, I., Zeb, A., Ullah, F., & Shah, M. R. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-0998-z · Cited by 99
Application of quercetin in neurological disorders: from nutrition to nanomedicine
Amanzadeh, E., Esmaeili, A., Rahgozar, S., & Nourbakhshnia, M. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0080 · Cited by 92
Postu, P. A., Sadiki, F. Z., El Idrissi, M., Cioanca, O., Trifan, A., Hancianu, M., & Hritcu, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108673 · Cited by 92
Rashed, A. A., Rahman, A. Z. A., & Rathi, D.-N. G. (2021) · Molecules · doi:10.3390/molecules26041107 · Cited by 90 · cited 1×
“Moreover, many other essential oils from various sources have been investigated in the past decade as antioxidant treatment options for neurodegenerative diseases [104].”
BackgroundRole of Quercetin Benefits in Neurodegeneration
Elumalai, P., & Lakshmi, S. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_12 · Cited by 88
Tepe, A. S., & Özaslan, M. (2020) · Industrial Crops and Products · doi:10.1016/j.indcrop.2019.112069 · Cited by 83
Kohoude, M. J., Gbaguidi, F. A., Agbani, P., Ayedoun, M.-A., Cazaux, S., & Bouajila, J. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1226356 · Cited by 78
Onose, G., Anghelescu, A., Blendea, D. C., Ciobanu, V., Daia, C. O., Firan, F. C., Oprea, M., Spînu, A., Popescu, C., Ionescu, A. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020907 · Cited by 78 · cited 1×
“A feature that has been noticed to be common to neurodegenerative diseases is oxidative stress (OS) resulting from the unregulated production of reactive oxygen species (ROS) [7,8].”
BackgroundA Review on the Use of Essential Oil-Based Nanoformulations in Control of Mosquitoes
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac115.1251612529 · Cited by 77 · cited 1×
“Essential oils are volatile compounds that occur naturally, being synthesized by plants [102].”
BackgroundSuperoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
Lazzari, F. D., Bubacco, L., Whitworth, A. J., & Bisaglia, M. (2018) · Aging and Disease · doi:10.14336/ad.2017.1018 · Cited by 73 · cited 1×
“Thus, tackling SOD has been proven a useful tool against various diseases [78,79], including AD [80], PD [81], and ALS [82,83].”
Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review
Essa, M. M., Moghadas, M., Ba-Omar, T., Qoronfleh, M. W., Guillemin, G. J., Manivasagam, T., Justin‐Thenmozhi, A., Ray, B., Bhat, A., Chidambaram, S. B., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9989-9 · Cited by 69 · cited 1×
“Therefore, using antioxidants may provide an interesting option for better managing neurodegenerative diseases [64,72,73].”
BackgroundSadiki, F. Z., Idrissi, M. E., Cioancă, O., Trifan, A., Hăncianu, M., Hriţcu, L., & Postu, P. A. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.032 · Cited by 65
Abuhamdah, S. M. A., Abuhamdah, R. M. A., Howes, M. R., Al-Olimat, S., Ennaceur, A., & Chazot, P. L. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12424 · Cited by 63
Cutillas, A., Carrasco, A., Martinez‐Gutierrez, R., Tomas, V., & Tudela, J. (2017) · Chemistry & Biodiversity · doi:10.1002/cbdv.201700102 · Cited by 61
Bond, L., Bernhardt, K. D., Madria, P., Sorrentino, K., Scelsi, H. F., & Mitchell, C. S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00010 · Cited by 60
Moghaddam, M. H., Bayat, A., Eskandari, N., Abdollahifar, M., Fotouhi, F., Forouzannia, S. A., Rafiei, R., Hatari, S., Seraj, A., Shahidi, A. M. E. J., et al. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147444 · Cited by 59 · cited 5×
“Therefore, the inflammatory response does not perform accordingly, generating neuroinflammation in CNS [31,60,69].”
BackgroundInfluentialZengin, G., Sarıkürkçü, C., Aktümsek, A., & Ceylan, R. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 58
Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?
Bono-Yagüe, J., Gómez-Escribano, A. P., Millán, J. M., & Vázquez‐Manrique, R. P. (2020) · Antioxidants · doi:10.3390/antiox9070577 · Cited by 55
Encapsulation Systems for Delivery of Flavonoids: A Review
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac116.1393413951 · Cited by 53 · cited 1×
“Because OS can attack multiple molecular pathways that affect neuronal structures, altering OS in the biological environment, either by reducing the overproduction of free radicals or through the defense mechanisms of antioxidants, provides possible therapies for managing neurodegenerative disorders [72,74].”
BackgroundAdemosun, A. O., Oboh, G., Olupona, A. J., Oyeleye, S. I., Adewuni, T. M., & Nwanna, E. E. (2016) · Journal of Food Biochemistry · doi:10.1111/jfbc.12187 · Cited by 52
Cutillas, A.-B., Carrasco, A., Martinez-Gutierrez, R., Tomas, V., & Tudela, J. (2018) · PLOS ONE · doi:10.1371/journal.pone.0190790 · Cited by 50
Tamtaji, O. R., Hadinezhad, T., Fallah, M., Shahmirzadi, A. R., Taghizadeh, M., Behnam, M., & Asemi, Z. (2020) · Current Drug Targets · doi:10.2174/1389450120666191112155654 · Cited by 50
Bahadori, M. B., Maggi, F., Zengin, G., Asghari, B., & Eskandani, M. (2020) · Industrial Crops and Products · doi:10.1016/j.indcrop.2020.112089 · Cited by 49
Significance of Antioxidants in the Treatment and Prevention of Neurodegenerative Diseases
Fadaka, A. O., Ajiboye, B. O., Adewale, I., Ojo, O. A., Oyinloye, B. E., & Okesola, M. A. (2019) · The Journal of Phytopharmacology · doi:10.31254/phyto.2019.8210 · Cited by 47
Nikolova, G., Karamalakova, Y. D., Kovacheva, N., Stanev, S., Zheleva, A. M., & Gadjeva, V. G. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.06.024 · Cited by 44
Panahi, Y., Rajaee, S. M., Johnston, T. P., & Sahebkar, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26536 · Cited by 41 · cited 5×
“Moreover, the lack of vitamin E in the human body has been linked with the incidence of neurodegenerative disorders [72,87].”
BackgroundInfluentialNeuroprotective Natural Molecules, From Food to Brain
González-Fuentes, J., Selva, J. S., Moya‐López, C., Castro‐Vázquez, L., Lozano, M. V., Marcos, P., Plaza-Oliver, M., Robledo, V. R., Santander-Ortega, M. J., Villaseca-González, N., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00721 · Cited by 41 · cited 8×
“Therefore, the inflammatory response does not perform accordingly, generating neuroinflammation in CNS [31,60,69].”
BackgroundInfluentialNikolova, G., Karamalakova, Y. D., & Gadjeva, V. G. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.03.006 · Cited by 41
Emerging Promise of Nanoparticle-Based Treatment for Parkinson’s disease
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac106.71357151 · Cited by 36 · cited 1×
“, 5%) in people over 80 years old [1,13,21,22].”
Background(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac113.98719879 · Cited by 34
Tobore, T. O. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24492 · Cited by 32
Zhao, B., Marciniuk, K., Gibbs, E., Yousefi, M., Napper, S., & Cashman, N. R. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.044 · Cited by 31
Bioactive Lipids: Chemistry & Health Benefits
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac106.66766687 · Cited by 31 · cited 1×
“Therefore, using antioxidants may provide an interesting option for better managing neurodegenerative diseases [64,72,73].”
BackgroundIssa, M. Y., Ezzat, M. I., Sayed, R. H., Elbaz, E. M., Omar, F. A., & Mohsen, E. (2020) · South African Journal of Botany · doi:10.1016/j.sajb.2020.04.032 · Cited by 30
New Candidate Delivery System for Alzheimer’s Disease: Deferoxamine Nanogels
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac106.71067119 · Cited by 30 · cited 1×
“Breathtakingly, the report outlines that, globally, there will be a new case of dementia every three seconds [40,41].”
BackgroundAli-Shtayeh, M. S., Jamous, R. M., Abu-Zaitoun, S. Y., Akkawi, R. J., Kalbouneh, S. R., Bernstein, N., & Dudai, N. (2018) · Industrial Crops and Products · doi:10.1016/j.indcrop.2018.08.038 · Cited by 29
Investigation of the Antioxidant and Antibacterial Activity of Novel Quercetin Derivatives
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac106.73297336 · Cited by 22
McLimans, K. E., Clark, B. E., Plagman, A. K., Pappas, C. A., Klinedinst, B. S., Anatharam, V., Kanthasamy, A. G., Willette, A. A., & Initiative, A. D. N. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7762 · Cited by 21
A Synthetic SOD/Catalase Mimic Compound for the Treatment of ALS
Soll, M., Goldshtein, H., Rotkopf, R., Russek‐Blum, N., & Gross, Z. (2021) · Antioxidants · doi:10.3390/antiox10060827 · Cited by 17 · cited 17×
“A series of relevant clinical trials have been priorly reported connecting ALS with oxidative stress and attempting to combat its various mechanisms of action.”
InfluentialHaney, M. J., Klyachko, N. L., Zhao, Y., Kabanov, A. V., & Batrakova, E. V. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.396 · Cited by 14
Sevindik, H. G., Özek, T., Yerdelen, K. Ö., Önal, M., Özbek, H., Güvenalp, Z., & Demirezer, L. Ö. (2016) · Hacettepe University Institutional Repository (hacettepe.edu.tr) · Cited by 13
Interplay between antioxidant activity, health and disease
Kazakov, Y. E., Tarasov, A. V., Alyoshina, L., & Brainina, K. Z. (2019) · Biointerface Research in Applied Chemistry · doi:10.33263/briac101.893901 · Cited by 12 · cited 1×
“Even though results have indicated that ROS do not represent a triggering factor in these diseases, they can probably aggravate disease progression due to oxidative damage as well as their interaction with mitochondria [1,12].”
Background(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac112.94329442 · Cited by 11 · cited 1×
“On the other hand, the endogenous sources are either mitochondrial or nonmitochondrial ROS-developing enzymes [13,14].”
BackgroundMacKenzie, J. L., Ivanova, N., Nell, H. J., Giordano, C. R., Terlecky, S. R., Agca, C., Ağca, Y., Walton, P. A., Whitehead, S. N., & Cechetto, D. F. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.01.026 · Cited by 10 · cited 1×
“Catalase treatment was reported to ameliorate memory deficit in AD [84], attenuate neurotoxicity and neuroinflammation [85], and provide significant neuroprotective effects in PD [86].”
BackgroundPhytomicrobiome Studies for Combating the Abiotic Stress
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac113.1049310509 · Cited by 8 · cited 2×
“Protein oxidation is also increasingly recognized as relevant, especially because oxidized proteins may gain a toxic function by forming cytotoxic aggregates [16,17].”
BackgroundNeuroinflammation and Neurodegeneration
Peterson, P. K., & Toborek, M. (2014) · Springer: New York · doi:10.1007/978-1-4939-1071-7 · Cited by 6
Rahman, M. R., Islam, T., Shahjaman, M., Rana, M. H. K., Holsinger, R. M. D., Quinn, J. M. W., Göv, E., & Moni, M. A. (2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac112.86868701 · Cited by 4 · cited 1×
“Moreover, due to the lowering of estrogen levels during menopause and longer life expectancy, women are more likely to develop AD than men [42,43].”
Background
Cited by
Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 700
“Scientists hope to discover new paths for therapy and prevention by better understanding the complicated interplay between oxidative stress and neurological disorders, thereby enhancing the quality of life for people affected by these conditions 6 .”
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Tumilaar, S. G., Hardianto, A., Dohi, H., & Kurnia, D. (2024) · Journal of Chemistry · doi:10.1155/2024/5594386 · Cited by 265
Oxidative stress in Alzheimer’s disease: current knowledge of signaling pathways and therapeutics
Dhapola, R., Beura, S. K., Sharma, P., Singh, S. K., & HariKrishnaReddy, D. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09021-z · Cited by 252
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Al-Ghraiybah, N. F., Wang, J., Alkhalifa, A. E., Roberts, A. B., Raj, R., Yang, E., & Kaddoumi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810572 · Cited by 202
“In addition to stress, heavy metal toxicity could increase neuroinflammation by acting as catalytic agents for redox reactions, thus, increasing oxidative stress [49,50]; alternatively, heavy metals could cause protein misfolding [51,52].”
Background
Metadata
- Authors
- Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I.
- Affiliations
- Carol Davila University of Medicine and Pharmacy (RO)
- Universitatea Națională de Știință și Tehnologie Politehnica București (RO)
- National Institute for Laser Plasma and Radiation Physics (RO)
- Bucharest Emergency University Hospital (RO)
- Grigore T. Popa University of Medicine and Pharmacy (RO)
- University of Bucharest (RO)
- Corresponding author
- Grumezescu, Alexandru Mihai
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-05-25
- Volume
- 23
- Issue
- 11
- Pages
- 5938
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9180653
- OpenAlex
- W4281569188
- Cited by
- 1,085
- References
- 105
- Citations by year
- 2026: 270 · 2025: 405 · 2024: 254 · 2023: 132 · 2022: 23
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- oxidative stress, neuroinflammation, neurodegenerative diseases, reactive oxygen species, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, antioxidants, antioxidant enzymes, non-enzymatic antioxidants
- MeSH terms
- Neuroinflammatory Diseases, Antioxidants, Humans, Reactive Oxygen Species, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.